Evidence map›Paper›PMID 35283094›Full record

ArticleClinica chimica acta; international journal of clinical chemistry2022

Proline-specific peptidase activities (DPP4, PRCP, FAP and PREP) in plasma of hospitalized COVID-19 patients.

An Bracke, Emilie De Hert, Michelle De Bruyn, Karen Claesen, Gwendolyn Vliegen, Alexandra Vujkovic, Lida van Petersen, Fien H R De Winter, An Hotterbeekx, Isabel Brosius and 9 more

Open access · greenAbstract read
In one paragraph

Article in Clinica chimica acta; international journal of clinical chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Identification and validation of mFrontiers in immunology · 2025
    Article
  3. Article
  4. ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2/ACE ratio and potential RAAS dysregulation in severe cases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Article
  5. Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned?International journal of molecular sciences · 2023
    Review
  6. Review
  7. Review
  8. COVID-19, vaccines and deficiency of ACEEuropean journal of internal medicine · 2022
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

An BrackeLaboratory of Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Belgium.
Emilie De HertLaboratory of Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Belgium.
Michelle De BruynLaboratory of Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Belgium.
Karen ClaesenLaboratory of Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Belgium.
Gwendolyn VliegenLaboratory of Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Belgium.
Alexandra VujkovicInstitute of Tropical Medicine, Antwerp, Belgium; Clinical Virology Unit, Institute of Tropical Medicine, Antwerp, Belgium.
Lida van PetersenInstitute of Tropical Medicine, Antwerp, Belgium.
Fien H R De WinterMolecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medical & Health Sciences, University of Antwerp, Antwerp, Belgium.
An HotterbeekxMolecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medical & Health Sciences, University of Antwerp, Antwerp, Belgium.
Isabel BrosiusInstitute of Tropical Medicine, Antwerp, Belgium.
Caroline TheunissenInstitute of Tropical Medicine, Antwerp, Belgium.
Sabrina Van IersselDepartment of General Internal Medicine, Infectious Diseases and Tropical Medicine, University Hospital, Antwerp, Belgium.
Maartje van FrankenhuijsenInstitute of Tropical Medicine, Antwerp, Belgium.
Erika VliegheDepartment of General Internal Medicine, Infectious Diseases and Tropical Medicine, University Hospital, Antwerp, Belgium.
Koen VercauterenInstitute of Tropical Medicine, Antwerp, Belgium; Clinical Virology Unit, Institute of Tropical Medicine, Antwerp, Belgium.
Pieter Van der VekenLaboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.
Dirk HendriksLaboratory of Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Belgium.
Samir Kumar-SinghMolecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medical & Health Sciences, University of Antwerp, Antwerp, Belgium.
Ingrid De MeesterLaboratory of Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Belgium. Electronic address: Ingrid.demeester@uantwerpen.be.
University of Antwerp · BEInstituut voor Tropische Geneeskunde · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 patients experience several features of dysregulated immune system observed in sepsis. We previously showed a dysregulation of several proline-selective peptidases such as dipeptidyl peptidase 4 (DPP4), fibroblast activation protein alpha (FAP), prolyl oligopeptidase (PREP) and prolylcarboxypeptidase (PRCP) in sepsis. In this study, we investigated whether these peptidases are similarly dysregulated in hospitalized COVID-19 patients.

methodsFifty-six hospitalized COVID-19 patients and 32 healthy controls were included. Enzymatic activities of DPP4, FAP, PREP and PRCP were measured in samples collected shortly after hospital admission and in longitudinal follow-up samples.

resultsCompared to healthy controls, both DPP4 and FAP activities were significantly lower in COVID-19 patients at hospital admission and FAP activity further decreased significantly in the first week of hospitalization. While PRCP activity remained unchanged, PREP activity was significantly increased in COVID-19 patients at hospitalization and further increased during hospital stay and stayed elevated until the day of discharge.

conclusionThe changes in activities of proline-selective peptidases in plasma are very similar in COVID-19 and septic shock patients. The pronounced decrease in FAP activity deserves further investigation, both from a pathophysiological viewpoint and as its utility as a part of a biomarker panel.

Indexed as

COVID-19Shock, SepticCarboxypeptidasesDipeptidyl Peptidase 4EndopeptidasesFibroblast Activation Protein AlphaGelatinasesHumansMembrane ProteinsPeptide HydrolasesProlineSerine EndopeptidasesCarboxypeptidasesDipeptidyl Peptidase 4DPP4 protein, humanEndopeptidasesFibroblast Activation Protein AlphaGelatinaseslysosomal Pro-X carboxypeptidaseMembrane ProteinsPeptide HydrolasesProlineSerine EndopeptidasesCoronavirusCOVID-19Dipeptidyl peptidase 4Fibroblast activation protein alphaProlylcarboxypeptidaseProlyl oligopeptidase

Identifiers

PMID35283094
PMCPMC8920094
OpenAlexW4220701256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.